Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Autosomal dominant tubulointerstitial kidney disease

O. Devuyst, E. Olinger, S. Weber, KU. Eckardt, S. Kmoch, L. Rampoldi, AJ. Bleyer,

. 2019 ; 5 (1) : 60. [pub] 20190905

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc20025664

Grantová podpora
NV17-29786A MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Článek

E-zdroje Online Plný text

NLK ProQuest Central od 2015-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2015-01-01 do Před 1 rokem

Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a recently defined entity that includes rare kidney diseases characterized by tubular damage and interstitial fibrosis in the absence of glomerular lesions, with inescapable progression to end-stage renal disease. These diseases have long been neglected and under-recognized, in part due to confusing and inconsistent terminology. The introduction of a gene-based, unifying terminology led to the identification of an increasing number of cases, with recent data suggesting that ADTKD is one of the more common monogenic kidney diseases after autosomal dominant polycystic kidney disease, accounting for ~5% of monogenic disorders causing chronic kidney disease. ADTKD is caused by mutations in at least five different genes, including UMOD, MUC1, REN, HNF1B and, more rarely, SEC61A1. These genes encode various proteins with renal and extra-renal functions. The mundane clinical characteristics and lack of appreciation of family history often result in a failure to diagnose ADTKD. This Primer highlights the different types of ADTKD and discusses the distinct genetic and clinical features as well as the underlying mechanisms.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025664
003      
CZ-PrNML
005      
20201222154026.0
007      
ta
008      
201125s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41572-019-0109-9 $2 doi
035    __
$a (PubMed)31488840
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Devuyst, Olivier $u Institute of Physiology, Mechanisms of Inherited Kidney Disorders Group, University of Zurich, Zurich, Switzerland. olivier.devuyst@uzh.ch. Division of Nephrology, UCLouvain Medical School, Brussels, Belgium. olivier.devuyst@uzh.ch.
245    10
$a Autosomal dominant tubulointerstitial kidney disease / $c O. Devuyst, E. Olinger, S. Weber, KU. Eckardt, S. Kmoch, L. Rampoldi, AJ. Bleyer,
520    9_
$a Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a recently defined entity that includes rare kidney diseases characterized by tubular damage and interstitial fibrosis in the absence of glomerular lesions, with inescapable progression to end-stage renal disease. These diseases have long been neglected and under-recognized, in part due to confusing and inconsistent terminology. The introduction of a gene-based, unifying terminology led to the identification of an increasing number of cases, with recent data suggesting that ADTKD is one of the more common monogenic kidney diseases after autosomal dominant polycystic kidney disease, accounting for ~5% of monogenic disorders causing chronic kidney disease. ADTKD is caused by mutations in at least five different genes, including UMOD, MUC1, REN, HNF1B and, more rarely, SEC61A1. These genes encode various proteins with renal and extra-renal functions. The mundane clinical characteristics and lack of appreciation of family history often result in a failure to diagnose ADTKD. This Primer highlights the different types of ADTKD and discusses the distinct genetic and clinical features as well as the underlying mechanisms.
650    _2
$a biopsie $x metody $7 D001706
650    _2
$a genetické nemoci vrozené $x komplikace $x epidemiologie $7 D030342
650    _2
$a lidé $7 D006801
650    _2
$a chronické selhání ledvin $x epidemiologie $x etiologie $7 D007676
650    _2
$a polycystické ledviny autozomálně dominantní $x komplikace $x epidemiologie $x patofyziologie $7 D016891
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Olinger, Eric $u Institute of Physiology, Mechanisms of Inherited Kidney Disorders Group, University of Zurich, Zurich, Switzerland.
700    1_
$a Weber, Stefanie $u Division of Pediatric Nephrology and Transplantation, University Children's Hospital Marburg, Marburg, Germany.
700    1_
$a Eckardt, Kai-Uwe $u Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Berlin, Germany.
700    1_
$a Kmoch, Stanislav $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Rampoldi, Luca $u Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
700    1_
$a Bleyer, Anthony J $u Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
773    0_
$w MED00200655 $t Nature reviews. Disease primers $x 2056-676X $g Roč. 5, č. 1 (2019), s. 60
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31488840 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222154022 $b ABA008
999    __
$a ok $b bmc $g 1599809 $s 1116350
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 5 $c 1 $d 60 $e 20190905 $i 2056-676X $m Nature reviews. Disease primers $n Nat Rev Dis Primers $x MED00200655
GRA    __
$a NV17-29786A $p MZ0
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...